Skip to Main Content

Alzheimer’s disease is often broadly referred to as “Type 3 diabetes,” because it’s thought that glucose processing goes haywire in the neurodegenerative disease, just as it does in diabetes.

A new National Institutes of Health study adds some credence to that theory, finding that glitches in the way the brain breaks down glucose — a process called glycolysis — seem to correspond with more severe symptoms in patients with Alzheimer’s.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Comments are closed.